T cell exhaustion
- PMID: 21739672
- DOI: 10.1038/ni.2035
T cell exhaustion
Abstract
T cell exhaustion is a state of T cell dysfunction that arises during many chronic infections and cancer. It is defined by poor effector function, sustained expression of inhibitory receptors and a transcriptional state distinct from that of functional effector or memory T cells. Exhaustion prevents optimal control of infection and tumors. Recently, a clearer picture of the functional and phenotypic profile of exhausted T cells has emerged and T cell exhaustion has been defined in many experimental and clinical settings. Although the pathways involved remain to be fully defined, advances in the molecular delineation of T cell exhaustion are clarifying the underlying causes of this state of differentiation and also suggest promising therapeutic opportunities.
Similar articles
-
Transcription factor regulation of CD8+ T-cell memory and exhaustion.Immunol Rev. 2010 Jul;236:167-75. doi: 10.1111/j.1600-065X.2010.00927.x. Immunol Rev. 2010. PMID: 20636816 Review.
-
Molecular and cellular insights into T cell exhaustion.Nat Rev Immunol. 2015 Aug;15(8):486-99. doi: 10.1038/nri3862. Nat Rev Immunol. 2015. PMID: 26205583 Free PMC article. Review.
-
Understand memory, design better vaccines.Nat Immunol. 2011 Jun;12(6):463-5. doi: 10.1038/ni.2041. Nat Immunol. 2011. PMID: 21587308 Free PMC article.
-
Heterogeneity and fate choice: T cell exhaustion in cancer and chronic infections.Curr Opin Immunol. 2019 Jun;58:98-103. doi: 10.1016/j.coi.2019.04.014. Epub 2019 Jun 8. Curr Opin Immunol. 2019. PMID: 31181510 Free PMC article. Review.
-
Exhausted CD8 T cells downregulate the IL-18 receptor and become unresponsive to inflammatory cytokines and bacterial co-infections.PLoS Pathog. 2011 Sep;7(9):e1002273. doi: 10.1371/journal.ppat.1002273. Epub 2011 Sep 29. PLoS Pathog. 2011. PMID: 21980291 Free PMC article.
Cited by
-
IL-18R supported CAR T cells targeting oncofetal tenascin C for the immunotherapy of pediatric sarcoma and brain tumors.J Immunother Cancer. 2024 Nov 20;12(11):e009743. doi: 10.1136/jitc-2024-009743. J Immunother Cancer. 2024. PMID: 39572158 Free PMC article.
-
Targeting mitochondria: restoring the antitumor efficacy of exhausted T cells.Mol Cancer. 2024 Nov 19;23(1):260. doi: 10.1186/s12943-024-02175-9. Mol Cancer. 2024. PMID: 39563438 Free PMC article. Review.
-
Factors Influencing Immunotherapy Outcomes in Cancer: Sarcopenia and Systemic Inflammation.Cancer Control. 2024 Jan-Dec;31:10732748241302248. doi: 10.1177/10732748241302248. Cancer Control. 2024. PMID: 39547932 Free PMC article.
-
Epigenetics behind CD8+ T cell activation and exhaustion.Genes Immun. 2024 Dec;25(6):525-540. doi: 10.1038/s41435-024-00307-1. Epub 2024 Nov 14. Genes Immun. 2024. PMID: 39543311 Review.
-
Lipid metabolism-related gene signature predicts prognosis and unveils novel anti-tumor drugs in specific type of diffuse large B cell lymphoma.Mol Med. 2024 Nov 13;30(1):210. doi: 10.1186/s10020-024-00988-4. Mol Med. 2024. PMID: 39538125 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources